BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 16, 2026
Home
»
Topics
»
Disease categories and therapies
» Musculoskeletal
Musculoskeletal
RSS
Eisai to collaborate with Toyama in development, marketing of DMARD
Nov. 5, 1998
Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy
Nov. 5, 1998
SmithKline Beecham describes new cannabinoid receptor agonists
Nov. 5, 1998
Aryl C-glycosides as selectin inhibitors jointly developed by Sankyo, Glycomed
Nov. 5, 1998
Potent and selective COX-2 inhibitors from Merck Frosst useful for inflammation
Nov. 4, 1998
Korean laboratory prepares new series of TNF-alpha inhibitors
Nov. 4, 1998
FDA approves, Immunex launches breakthrough treatment for RA
Nov. 3, 1998
Orally active collagenase inhibitor Ro-32-3555 shows potential for osteoarthritis Rx
Nov. 3, 1998
Preparation and use of TNF-alpha and MMP inhibitors described by Novartis
Nov. 3, 1998
Safety and efficacy of COX-2 inhibitor established in phase II trials
Nov. 2, 1998
Previous
1
2
…
539
540
541
542
543
544
545
546
547
…
605
606
Next